SCHEMBL6356334

SCHEMBL6356334

NNC(=O)c1ccc(Cc2ccccc2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
ALDH1A1 P00352 6/20 0.43
MAPT P10636 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
GAA P10253 2/20 0.43
NPC1 O15118 6/20 0.43
RAB9A P51151 6/20 0.43
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 4/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 3/20 0.43
TP53 P04637 2/20 0.43
POLB P06746 2/20 0.43
ABL1 P00519 1/20 0.43
NFKB1 P19838 1/20 0.43
MAPK1 P28482 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
HDAC1 Q13547 5/20 0.42
HDAC6 Q9UBN7 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28311788 0.87 HPGD (0.57) ALOX5ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL4158801 0.83 ALOX5 (0.51) ALOX5ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL4675103 0.82 ALOX5 (0.47) ALOX5ALDH1A1MAPTRAB9AKMT2A
SCHEMBL11437319 0.80 ALOX5 (0.49) ALOX5ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL11431832 0.79 ALOX5 (0.44) ALOX5ALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL7077550 0.79 LMNA (0.51) ALOX5ALDH1A1MAPTSMN1; SMN2GAA
SCHEMBL29130679 0.79 ALOX5 (0.44) ALOX5ALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL8791802 0.78 HDAC3 (0.45) ALOX5ALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL11433089 0.78 ALOX5 (0.43) ALOX5ALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL7830529 0.78 ERCC5 (0.59) ALOX5MAPTKMT2APOLBHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050154048-A1 Novel acyl hydrazino thiophene derivatives, process for preparing them, their use as medicinal products, pharmaceutical compositions and novel use AVENTIS PHARMA S.A. (FR) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050154048-A1 Novel acyl hydrazino thiophene derivatives, process for preparing them, their use as medicinal products, pharmaceutical compositions and novel use CTSZ, CTSE, CTSS ALOX5 799/4885ALDH1A1 959/4885MAPT 3040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.